Samsara BioCapital, L.P. - 04 Sep 2025 SCHEDULE 13D/A Report for MINERALYS THERAPEUTICS, INC. Common Stock (MLYS)

Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Srinivas Akkaraju
Security
MINERALYS THERAPEUTICS, INC. Common Stock
Symbol
MLYS
Shares outstanding
77,392,610 shares
Disclosed Ownership
6,346,194 shares
Ownership
8.2%
Form type
SCHEDULE 13D/A
Filing time
08 Sep 2025, 20:05:45 UTC
Date of event
04 Sep 2025
Previous filing
17 Mar 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 7.3% 5,674,916 0 5,674,916 /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0001699737
Samsara BioCapital GP, LLC 7.3% 5,674,916 0 5,674,916 /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0001888829
Samsara Opportunity Fund, L.P. 0.8% 588,235 0 588,235 /s/ Srinivas Akkaraju By Samsara Opportunity Fund GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member
Samsara Opportunity Fund GP, LLC 0.8% 588,235 0 588,235 /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member
Srinivas Akkaraju 8.2% 6,346,194 83,043 6,263,151 /s/ Srinivas Akkaraju Srinivas Akkaraju 0001253170